 2. Tissue expression of Phospho-epidermal growth factor receptor EGFR, VEGF, vessel count CD3134, AKT and Phospho-AKT, mitogen-activated protein kinase MAPK, transforming growth factor-alpha TGF-alpha, phospho-STAT3 and TUNEL post therapy optional studies. 